Jan 12, 2026
Abercrombie Tightens Sales Outlook, Flags Tariff Pressure

Abercrombie & Fitch Co. (NYSE:ANF) announced on Monday that it has tightened its fiscal 2025 outlook, narrowing its annual sales growth forecast, despite reporting record quarter-to-date net sales through December. The retailer now expects full-year net sales growth of at…

Jan 12, 2026
Looking At Novo Nordisk’s Recent Unusual Options Activity

Deep-pocketed investors have adopted a bearish approach towards Novo Nordisk (NYSE:NVO), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such…

Jan 12, 2026
A Closer Look at RTX’s Options Market Dynamics

Investors with a lot of money to spend have taken a bullish stance on RTX (NYSE:RTX). And retail traders should know. We noticed this today when the positions showed up on publicly available options history that we track here at…

Jan 12, 2026
Apple Partners With Google’s Gemini AI To Power Siri

Apple Inc. (NASDAQ:AAPL) is stepping up its artificial intelligence push as competition intensifies across Big Tech and investor focus sharpens on how quickly the company can deliver meaningful AI upgrades. Apple Taps Google To Power AI Features Apple is teaming…

Jan 12, 2026
Johnson & Johnson Therapy Delivers Strong Results In Colorectal Cancer Trial

On Saturday, Johnson & Johnson (NYSE:JNJ) shared new longer follow-up results from the Phase 1b/2 OrigAMI-1 study. The trial is evaluating Rybrevant (amivantamab-vmjw) in combination with FOLFOX or FOLFIRI chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer. The company said that…

Jan 12, 2026
Gold Rises Sharply; Lyra Therapeutics Shares Plunge

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 50 points on Monday. The Dow traded down 0.19% to 49,411.94 while the NASDAQ gained 0.29% to 23,740.51. The S&P 500 also rose, gaining, 0.04% to…